A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants
With Diabetic Macular Edema
Does the drug faricimab help patients with macular edema due to diabetes?
Basic Study Information
Purpose:Location: Retina Assoc of Western NY
This study will evaluate the efficacy, safety, and pharmacokinetics of faricimab administered
at 8-week intervals or as specified in the protocol following treatment initiation,
with aflibercept once every 8 weeks (Q8W), in participants with diabetic macular edema
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Reference Study ID Number: GR40398 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search